METTL3 and neoplasm: Taken all together, METTL3 acetylation triggered by ASP/NAM treatment elicited a suppressive effect on invasiveness of tumor cells via impacting on both pro-metastasis and anti-metastasis pathways in an m6A-dependent manner.